Channeling Steve Jobs
Service providers must focus on delivering a superior customer experience.
A 25-Year Retrospective on the Biotech Business
This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."
Oxidative Folding of Proteins in Escherichia Coli
The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins.
Optimizing Drug Delivery for Modern Biologics
This article discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
Consistent Production of Genetically Stable Mammalian Cell Lines
The author describes expression technology that produces cell lines with high genetic stability.
FDA Explores Options to Expand Access to NonPrescription Drugs
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
Development of an Alternative Monoclonal Antibody Polishing Step
MAb polishing using salt tolerant interaction membrane chromatography.
Choosing an Expression System
A Q&A with Alan Shaw of Vaxinnate. This article is part of a special section on expression systems.
A New Way to Think About Outsourcing Partnerships
Future sponsor-contract provider relationships will require more integration.
Applying Quality by Design to Lyophilization
Featuring expert insights from GSK Biologicals, Baxter Pharmaceutical Solutions, GEA Pharma Systems, and more.
Some Supply Chain Lessons Can Go a Long Way
No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.
How to Respond to Consent Decrees
How to handle and respond to a consent decree.
Changing Your Business Model
BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.
